Sweden advises against covid-19 vaccine Nuvaxovid for under 30s

Sweden advises against covid-19 vaccine Nuvaxovid for under 30s

, Nov. 2 (Xinhua) — Nuvaxovid, the covid-19 created by the American company Novavax, should not be given to people younger than 30, the Public Health Agency said here on Wednesday.

The agency cited research conducted in , which showed an increased risk of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) after vaccination.

“We are following the situation closely and are awaiting more data,” says Sören Andersson, head of the authority’s unit for vaccination programs, in a press release.

Around 7,000 doses of Nuvaxovid have already been administered in . The agency said younger people who had recently been vaccinated with Nuvaxovid had no reason to worry because “the risk is very small” and they could continue with the next dose of another type of vaccine.

Those 30 and older can still be vaccinated with Nuvaxovid, and the agency said the decision to limit use of the vaccine is temporary, pending further investigation.

Source: sn.dk


Posted

in

by

Related Posts